This disclosure relates to lipid disulfide prodrugs and in particular to lipid disulfide phosphodiester nucleosides and derivatives thereof, pharmaceutical compositions, and uses related thereto. According to one embodiment of the disclosure there is provided a compound of Formula I,
or pharmaceutically acceptable salts or derivatives thereof, wherein substitutents are disclosed herein.
本公开涉及二
硫化脂质原药,特别是二
硫化脂质
磷酸二酯核苷及其衍
生物、药物组合物和相关用途。根据本公开的一个实施方案,提供了式 I 的化合物、
或其药学上可接受的盐或衍
生物,其中的取代基已在本文中公开。